Divergent effects of endoscopic sphincterotomy on the long-term outcome of hepatolithiasis,☆☆,,★★,

https://doi.org/10.1016/S0016-5107(96)70257-2Get rights and content

Abstract

Background: The long-term value of endoscopic sphincterotomy in patients with hepatolithiasis has not been established. Methods: Long-term clinical effects of endoscopic sphincterotomy on hepatolithiasis were determined in 57 patients. All patients had sphincterotomy to remove their common bile duct stones. Intrahepatic stones were removed completely in 21 patients, while the stones partly remained in 36 patients despite combined use of surgery and/or percutaneous trans-hepatic choledochoscopy. Three patients of the latter group spontaneously passed all the remaining stones soon after the sphincterotomy. Results: Follow-up at 66 to 183 months (mean, 114 months) was available in 54 patients (94.7%). Late complications occurred in 10 patients with the remaining stones, including seven cases of cholangitis (two fatalities) and three of liver abscess (one fatality). In contrast, those with complete clearance developed no complications. Conclusions: Endoscopic sphincterotomy has divergent effects on the long-term outcome of patients with hepatolithiasis. Every effort should be made to remove the intrahepatic stones as completely as possible shortly after sphincterotomy if the patient is to be managed endoscopically and adverse effects are to be avoided. (Gastrointest Endosc 1996;43:33-7.)

Section snippets

MATERIALS AND METHODS

Fifty-seven patients with intrahepatic stones underwent ES for the treatment of coexistent common bile duct stones. Twenty-five patients were men and 32 women. The age ranged from 33 to 83 years with a mean of 56.7 years. The presence of the intrahepatic stones was known before ES in 32 patients (Group I), whereas it was demonstrated by post-ES investigations in the remaining 25 patients (Group II). ES was performed on an emergency basis to remove the common bile duct stones associated with

RESULTS

Follow-up data were available in 54 of 57 patients (95%). The mean follow-up period was 114 months (range, 66 to 183 months). Twenty-one patients were dead; 33 were alive. Causes of death were cholangiocarcinoma in 3 patients, late cholangitis in 2, liver abscess in 1, unknown in 2, and not related to hepatolithiasis in the other 13 (Table 1).

Intrahepatic stones had been completely cleared in 18 patients, whereas stones were only partially removed in 36 patients. Three patients in the latter

DISCUSSION

The present study demonstrates that ES has divergent effects on the long-term clinical outcome of patients with intrahepatic stones. Of 36 patients with incomplete clearance of the intrahepatic stones at the time of completion of ES and subsequent removal of common bile duct stones, 3 patients spontaneously passed all the remaining stones. Conversely, 10 of the 36 patients developed the potentially fatal complications of cholangitis (7) and liver abscess (3). The complications actually led to

Acknowledgements

We conclude that patients with intrahepatic stones after ES are at significant risk for subsequent biliary infection. Additional endoscopic, percutaneous, or surgical therapy is recommended to avoid serious cholangitis events associated with persistant intrahepatic stones.

References (21)

There are more references available in the full text version of this article.

Cited by (20)

  • Chapter 39 - Intrahepatic stones

    2016, Blumgart's Surgery of the Liver, Biliary Tract and Pancreas: Sixth Edition
  • Secondary Sclerosing Cholangitis. Pathogenesis, Diagnosis, and Management.

    2013, Clinics in Liver Disease
    Citation Excerpt :

    Surgery focuses on drainage and exploration of the bile ducts. Endoscopic intervention may also be used when needed, and long-term drainage may be the only option in a few patients with widespread disease.15,51,52 Conversely, therapeutic options in patients with AIDS cholangiopathy are limited, because none have been shown to be beneficial in improving survival.

  • Left-sided hepatic resection for hepatolithiasis: A longitudinal study of 110 patients

    2012, HPB
    Citation Excerpt :

    Treatment options include surgical treatment with biliary decompression and/or hepatic resection as the first approach.14,15 Non-surgical procedures such as percutaneous transhepatic lithotriphy or endoscopic therapy are usually reserved to treat stone recurrences.16,17 Morbidity and mortality rates for hepatic resection have decreased significantly in the last decade.5,18

  • Liver resection as the definitive treatment for unilateral non-oriental primary intrahepatic lithiasis

    2006, American Journal of Surgery
    Citation Excerpt :

    Hepatic resection for the treatment of hepatolithiasis has been reported to be associated with a low incidence of long-term stone recurrence or recurrent cholangitis [12–17]. The global rate of 7.4% of late complications in our series is relatively low when compared with recurrent/residual disease rates ranging between 20% and 40% reported in most studies after percutaneous cholangioscopic lithotripsy, or endoscopic or other surgical approaches such as bilioenteric anastomosis without hepatic resection [6–10,17,18]. In this study, to our knowledge the largest western PIHL series, the indications for resection were irreversible parenchyma or biliary lesions.

View all citing articles on Scopus

From the Departments of Surgery I, Kyushu University Faculty of Medicine, and Fukuoka University School of Medicine, Fukuoka, Japan.

☆☆

Reprint requests: Masao Tanaka, MD, Surgery I, Kyushu University Faculty of Medicine, Fukuoka 812, Japan.

0016-5107/96/4301-0033$5.00 + 0

★★

GASTROINTESTINAL ENDOSCOPY

37/1/65957

View full text